| Objective:To investigate the effect of I, NT-BNP and clinical effect of the treatment of chronic heart failure with
Qishenyiqi pills.Methods:60 cases of patients with chronic heart failure treatment were selected and randomly divided into experimental
group and control group with 30 cases in each group, the control group were treated with benazepril hydrochloride tablets 10 mg/time, 1
times/d; Furosemide Tablets 20 mg/time, 1 times /d; metoprolol sustained-release tablets 23.75 mg/time, 1 times / D; atorvastatin 20 mg/
time, 1 times /d; digoxin 0.125 mg/time, 1 times/d; Aspirin Enteric-coated Tablets 100 mg/time, Isosorbide Mononitrate Tablets
20mg/time 1time /d; the patients in the experimental group on the basis of the control group, Qishenyiqi pills, a 1 bag, 3 times /d, for 4
weeks after the end of treatment. The serum NT-BNP, patients with hs-CRP, cTn I levels were detected and compared.Results:Compared
with before treatment, after treatment in patients with serumNT-BNP, hs CRP, cTnI water decreased (P<0.05); compared with the
control group, patients in the experimental group the serumNT-BNP, hs CRP, cTnI level is low, clinical treatment, the total effective rate
was higher (P < 0.05).Conclusion:Qi Shen Qi pill can reduce the serumlevels of BNP - hs-CRP, cTn, I NT in patients with chronic heart
failure, the clinical efficacy is good, it has guiding significance for clinical. |
